Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ernesto Sparrelid to Liver Neoplasms

This is a "connection" page, showing publications Ernesto Sparrelid has written about Liver Neoplasms.

 
Connection Strength
  
 
 
9.924
  
  1. Reese T, Engstrand J, Björk D, Ottestad AM, Kiim KS, Evers M, Larsen PN, Schultz NA, Røsok BI, Carling U, Holmquist F, Lindell G, Sandström P, Böcker J, Gilg S, Sturesson C, Oldhafer KJ, Björnsson B, Sparrelid E. Propensity matched comparison between one-stage and two-stage hepatectomy after portal vein embolization for bilateral colorectal liver metastases. Eur J Surg Oncol. 2026 07; 52(7):111884.
    View in: PubMed
    Score: 0.598
  2. Reese T, Björk D, Longva AMH, Kiim KS, Evers M, Larsen PN, Schultz NA, Røsok BI, Carling U, Holmquist F, Lindell G, Sandström P, Böcker J, Gilg S, Engstrand J, Sturesson C, Oldhafer KJ, Björnsson B, Sparrelid E. Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases. Br J Surg. 2025 09 02; 112(9).
    View in: PubMed
    Score: 0.569
  3. Wang Q, Brismar TB, Björk D, Baubeta E, Lindell G, Björnsson B, Sparrelid E. Development and External Validation of a Combined Clinical-Radiomic Model for Predicting Insufficient Hypertrophy of the Future Liver Remnant following Portal Vein Embolization. Ann Surg Oncol. 2025 Mar; 32(3):1795-1807.
    View in: PubMed
    Score: 0.541
  4. Reese T, Gilg S, Böcker J, Wagner KC, Vali M, Engstrand J, Kern A, Sturesson C, Oldhafer KJ, Sparrelid E. Impact of the future liver remnant volume before major hepatectomy. Eur J Surg Oncol. 2024 11; 50(11):108660.
    View in: PubMed
    Score: 0.531
  5. Wang Q, Brismar TB, Gilg S, Jonas E, Nilsson H, Tzortzakakis A, Isaksson B, Axelsson R, Sparrelid E. Multimodal perioperative assessment of liver function and volume in patients undergoing hepatectomy for colorectal liver metastasis: a comparison of the indocyanine green retention test, 99mTc mebrofenin hepatobiliary scintigraphy and gadoxetic acid enhanced MRI. Br J Radiol. 2022 Oct 01; 95(1139):20220370.
    View in: PubMed
    Score: 0.465
  6. Holmberg M, Koppatz H, Jansson A, Hillingsø JG, Noergaard Larsen P, Lassen K, Sallinen V, Yaqub S, Sparrelid E. Secondary effects of the COVID-19 pandemic on surgical management of hepatopancreatobiliary malignancies in the Nordic capitals. Br J Surg. 2021 12 17; 109(1):e8-e9.
    View in: PubMed
    Score: 0.440
  7. Sparrelid E, Thorsen T, Sauter C, Jorns C, Stål P, Nordin A, de Boer MT, Buis C, Yaqub S, Schultz NA, Larsen PN, Sallinen V, Line PD, Gilg S. Liver transplantation in patients with post-hepatectomy liver failure - A Northern European multicenter cohort study. HPB (Oxford). 2022 07; 24(7):1138-1144.
    View in: PubMed
    Score: 0.440
  8. Villard C, Habib M, Nordenvall C, Nilsson PJ, Jorns C, Sparrelid E. Conversion therapy in patients with colorectal liver metastases. Eur J Surg Oncol. 2021 08; 47(8):2038-2045.
    View in: PubMed
    Score: 0.416
  9. Barimani D, Kauppila JH, Sturesson C, Sparrelid E. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review. World J Surg Oncol. 2020 Oct 08; 18(1):264.
    View in: PubMed
    Score: 0.405
  10. Sparrelid E, Jonas E, Tzortzakakis A, Dahlén U, Murquist G, Brismar T, Axelsson R, Isaksson B. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. J Gastrointest Surg. 2017 06; 21(6):967-974.
    View in: PubMed
    Score: 0.316
  11. Sparrelid E, Gilg S, Brismar TB, Lundell L, Isaksson B. Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases. Langenbecks Arch Surg. 2017 Feb; 402(1):69-75.
    View in: PubMed
    Score: 0.308
  12. Huang Y, Santoni G, Petrick JL, Wocalewski V, Sparrelid E, Xie SH. Menopausal hormone therapy and risk of liver cancer in a Swedish population-based cohort study. J Natl Cancer Inst. 2026 Aug 01; 118(8):1478-1484.
    View in: PubMed
    Score: 0.152
  13. Romell J, Moro CF, Brodin B, Szekely L, Porovic E, Tsagkozis P, Sparrelid E, Björnstedt M, Hertz HM. X-ray histology on rapidly fixed fresh tumor tissue samples for fast resection margin assessment. Sci Rep. 2026 Jul 11; 16(1).
    View in: PubMed
    Score: 0.151
  14. Huang Y, Santoni G, Sparrelid E, Xie SH. Metformin use and the risk of liver cancer in a Swedish population-based cohort study. JNCI Cancer Spectr. 2026 May 09; 10(3).
    View in: PubMed
    Score: 0.149
  15. Pilz da Cunha G, Aghayan D, Cipriani F, Chua DW, Morrison-Jones V, Lanari J, de Meyere C, Wei K, Tzedakis S, Martinie J, Bordom DO, Adel SE, Crespo K, Magistri P, Russolillo N, Conci S, Cacciaguerra AB, D'Souza D, Zozaya G, Caula C, Rehman S, Fretland ÅA, Koh YX, Besselinkz MG, van Dieren S, Geller D, Campos RR, Croner RS, Jovine E, Efanov M, Alseidi A, Memeo R, Dagher I, Giuliante F, Sparrelid E, Ahmad J, Gallagher T, Schmelzle M, White S, Ben SL, Rotellar F, Serrano PE, Vivarelli M, Ruzzenente A, Ferrero A, Di Benedetto F, Sucandy I, Sutcliffe RP, Vrochides D, Fuks D, Liu R, D'Hondt M, Cillo U, Primrose JN, Goh BKP, Ratti F, Edwin B, Abu Hilal M, Swijnenburg RJ. Conversion in Minimally Invasive Liver Surgery: The Impact of Conversion Urgency and Surgical Approach. Ann Surg Oncol. 2026 Jul; 33(7):6001-6012.
    View in: PubMed
    Score: 0.148
  16. Faseh L, Fruhling P, Taflin H, Lundmark Rystedt J, Williamsson C, Hemmingsson O, Björnsson B, Gerling M, Sparrelid E, Sandström P, Hasselgren K, Engstrand J. Real-world management of patients with simultaneously diagnosed synchronous liver and lung metastatic colorectal cancer - a national cohort study. Acta Oncol. 2026 Mar 12; 65:201-212.
    View in: PubMed
    Score: 0.148
  17. Björk D, Reese T, Holmen Longva AM, Kiim KS, Evers M, Larsen PN, Aagaard Schultz N, Røsok BI, Carling U, Holmquist F, Lindell G, Sandström P, Böcker J, Gilg S, Engstrand J, Sturesson C, Oldhafer KJ, Sparrelid E, Björnsson B. Comparing hypertrophy of the future liver remnant for two different strategies of portal vein embolization in patients with bilobar colorectal liver metastases - a retrospective European multicentre study. HPB (Oxford). 2026 Mar; 28(3):342-349.
    View in: PubMed
    Score: 0.145
  18. Nebbia M, Villard C, Gilg S, Sparrelid E, Gerling M, Engstrand J. Sex-Associated Aspects of Referral, Resectability, and Survival in Patients with Colorectal Liver Metastases (CRLM): A Population-Based Single-Center Study of 1207 MDT-Referred Patients. Ann Surg Oncol. 2026 Mar; 33(3):2527-2538.
    View in: PubMed
    Score: 0.145
  19. Hasselgren K, Williamsson C, Wennerblom J, Ghorbani P, Liljefors MG, Huhta H, Heby M, Månsson C, Johansson MI, Elander NO, Nortunen M, Kallio R, Halimi A, Öhlund D, Sandström P, Sparrelid E, Björnsson B. Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol. BMC Surg. 2025 Jul 19; 25(1):299.
    View in: PubMed
    Score: 0.141
  20. Sterner J, Andersson M, Olofsson A, Jansson H, Strömberg C, D'Souza M, Sturesson C, Sparrelid E, Gerling M, Gilg S, Engstrand J. Impact of post-hepatectomy liver failure on recurrence following major hepatectomy for colorectal cancer liver metastases. HPB (Oxford). 2025 Oct; 27(10):1309-1317.
    View in: PubMed
    Score: 0.141
  21. Perri G, Engstrand J, Wright RD, Bronzwaer SFC, Kroese TE, Huang B, Acidi B, Vitale A, Tran Cao HS, van Hillegersberg R, Nilsson M, Sparrelid E, Katz MHG, Marchegiani G, Cillo U. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open. 2025 07 01; 9(4).
    View in: PubMed
    Score: 0.141
  22. Yaqub S, Longva A, Angelsen JH, Brudvik KW, Carling U, Edwin B, Fretland ÅA, Grünhagen DJ, Line PD, Røsok BI, Smedman TM, Sparrelid E, Syversveen T, Villanger O, Lassen K. Multimodal treatment for colorectal liver metastases: A toolbox for clinicians. Scand J Surg. 2025 Jun; 114(2):126-134.
    View in: PubMed
    Score: 0.139
  23. Björk D, Carling U, Gilg S, Hasselgren K, Larsen PN, Lindell G, Røsok BI, Sandström P, Sturesson C, Tschuor C, Sparrelid E, Björnsson B. Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization-a retrospective scandinavian cohort study. Eur J Surg Oncol. 2025 07; 51(7):109995.
    View in: PubMed
    Score: 0.138
  24. Baumgartner R, Engstrand J, Rajala P, Grip J, Ghorbani P, Sparrelid E, Gilg S. Comparing the accuracy of prediction models to detect clinically relevant post-hepatectomy liver failure early after major hepatectomy. Br J Surg. 2024 01 03; 111(1).
    View in: PubMed
    Score: 0.127
  25. Primavesi F, Maglione M, Cipriani F, Denecke T, Oberkofler CE, Starlinger P, Dasari BVM, Heil J, Sgarbura O, Søreide K, Diaz-Nieto R, Fondevila C, Frampton AE, Geisel D, Henninger B, Hessheimer AJ, Lesurtel M, Mole D, Öllinger R, Olthof P, Reiberger T, Schnitzbauer AA, Schwarz C, Sparrelid E, Stockmann M, Truant S, Aldrighetti L, Braunwarth E, D'Hondt M, DeOliveira ML, Erdmann J, Fuks D, Gruenberger T, Kaczirek K, Malik H, Öfner D, Rahbari NN, Göbel G, Siriwardena AK, Stättner S. E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy. Br J Surg. 2023 09 06; 110(10):1331-1347.
    View in: PubMed
    Score: 0.124
  26. Fernández Moro C, Geyer N, Harrizi S, Hamidi Y, Söderqvist S, Kuznyecov D, Tidholm Qvist E, Salmonson Schaad M, Hermann L, Lindberg A, Heuchel RL, Martín-Bernabé A, Dhanjal S, Navis AC, Villard C, Del Valle AC, Bozóky L, Sparrelid E, Dirix L, Strell C, Östman A, Schmierer B, Vermeulen PB, Engstrand J, Bozóky B, Gerling M. An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver. Nat Commun. 2023 08 18; 14(1):5024.
    View in: PubMed
    Score: 0.124
  27. Hu X, Wang Q, Huang G, He X, Sparrelid E, Brismar TB, Fan Y. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma. Comput Math Methods Med. 2023; 2023:5424204.
    View in: PubMed
    Score: 0.119
  28. Gilg S, Sparrelid E, Engstrand J, Baumgartner R, Nowak G, Stål P, D'Souza M, Jansson A, Isaksson B, Jonas E, Stromberg C. Molecular adsorbent recirculating system treatment in patients with post-hepatectomy liver failure: Long-term results of a pilot study. Scand J Surg. 2022 Sep; 111(3):48-55.
    View in: PubMed
    Score: 0.115
  29. Baumgartner R, Gilg S, Björnsson B, Hasselgren K, Ghorbani P, Sauter C, Stål P, Sandstöm P, Sparrelid E, Engstrand J. Impact of post-hepatectomy liver failure on morbidity and short- and long-term survival after major hepatectomy. BJS Open. 2022 07 07; 6(4).
    View in: PubMed
    Score: 0.114
  30. Korenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B, van Baardewijk LJ, Baclija I, Bent C, Bertrand CL, Björnsson B, de Boer MT, de Boer SW, Bokkers RPH, Rinkes IHMB, Breitenstein S, Bruijnen RCG, Bruners P, Büchler MW, Camacho JC, Cappelli A, Carling U, Chan BKY, Chang DH, Choi J, Font JC, Crawford M, Croagh D, Cugat E, Davis R, De Boo DW, De Cobelli F, De Wispelaere JF, van Delden OM, Delle M, Detry O, Díaz-Nieto R, Dili A, Erdmann JI, Fisher O, Fondevila C, Fretland Å, Borobia FG, Gelabert A, Gérard L, Giuliante F, Gobardhan PD, Gómez F, Grünberger T, Grünhagen DJ, Guitart J, Hagendoorn J, Heil J, Heise D, Herrero E, Hess GF, Hoffmann MH, Iezzi R, Imani F, Nguyen J, Jovine E, Kalff JC, Kazemier G, Kingham TP, Kleeff J, Kollmar O, Leclercq WKG, Ben SL, Lucidi V, MacDonald A, Madoff DC, Manekeller S, Martel G, Mehrabi A, Mehrzad H, Meijerink MR, Menon K, Metrakos P, Meyer C, Moelker A, Modi S, Montanari N, Navines J, Neumann UP, Peddu P, Primrose JN, Qu X, Raptis D, Ratti F, Ridouani F, Rogan C, Ronellenfitsch U, Ryan S, Sallemi C, Moragues JS, Sandström P, Sarriá L, Schnitzbauer A, Serenari M, Serrablo A, Smits MLJ, Sparrelid E, Spüntrup E, Stavrou GA, Sutcliffe RP, Tancredi I, Tasse JC, Udupa V, Valenti D, Fundora Y, Vogl TJ, Wang X, White SA, Wohlgemuth WA, Yu D, Zijlstra IAJ, Binkert CA, Bemelmans MHA, van der Leij C, Schadde E, van Dam RM. Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy. Cardiovasc Intervent Radiol. 2022 09; 45(9):1391-1398.
    View in: PubMed
    Score: 0.114
  31. Villard C, Abdelrafee A, Habib M, Ndegwa N, Jorns C, Sparrelid E, Allard MA, Adam R. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model. Eur J Surg Oncol. 2022 Dec; 48(12):2432-2439.
    View in: PubMed
    Score: 0.114
  32. Strömberg C, Martinez de la Maza L, Fernández Moro C, Gerling M, Jorns C, Sparrelid E, Löhr MJ, Villard C. Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases. Eur J Surg Oncol. 2022 07; 48(7):1656-1663.
    View in: PubMed
    Score: 0.112
  33. Hasselgren K, Røsok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Larsson AL, Rizell M, Björnsson B, Sandström P. Response to Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM - It Is Time to Entry the IDEAL Stage 4?" Ann Surg. 2021 12 01; 274(6):e731-e732.
    View in: PubMed
    Score: 0.110
  34. Wang Q, Wang A, Sparrelid E, Zhang J, Zhao Y, Ma K, Brismar TB. Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review. Eur Radiol. 2022 Mar; 32(3):1792-1803.
    View in: PubMed
    Score: 0.108
  35. Yaqub S, Bjørnbeth BA, Angelsen JH, Fristrup CW, Grønbech JE, Hemmingsson O, Isaksson B, Juel IS, Larsen PN, Lindell G, Mortensen FV, Mortensen KE, Rizell M, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Taskén K. Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial. Trials. 2021 Sep 20; 22(1):642.
    View in: PubMed
    Score: 0.108
  36. Heil J, Heid F, Bechstein WO, Björnsson B, Brismar TB, Carling U, Erdmann J, Fretland ÅA, Grunhagen D, Hana RA, Hohmann J, Linke R, Meyer Y, Nawawi A, Olthof PB, Sandström P, Schnitzbauer AA, Sparrelid E, Verhoef C, Metrakos P, Schadde E. Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients. HPB (Oxford). 2022 03; 24(3):413-421.
    View in: PubMed
    Score: 0.107
  37. Wang Q, Chen S, Yan J, Brismar T, Sparrelid E, Qu C, Ji Y, Chen S, Ma K. Rescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma. BMC Surg. 2021 May 18; 21(1):246.
    View in: PubMed
    Score: 0.106
  38. Hasselgren K, Røsok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Larsson AL, Rizell M, Björnsson B, Sandström P. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021 03 01; 273(3):442-448.
    View in: PubMed
    Score: 0.104
  39. Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2020 Jul; 27(7):2311-2318.
    View in: PubMed
    Score: 0.097
  40. Tomassini F, D'Asseler Y, Linecker M, Giglio MC, Castro-Benitez C, Truant S, Axelsson R, Olthof PB, Montalti R, Serenari M, Chapelle T, Lucidi V, Sparrelid E, Adam R, Van Gulik T, Pruvot FR, Clavien PA, Bruzzese D, Geboes K, Troisi RI. Hepatobiliary scintigraphy and kinetic growth rate predict liver failure after ALPPS: a multi-institutional study. HPB (Oxford). 2020 10; 22(10):1420-1428.
    View in: PubMed
    Score: 0.097
  41. Björnsson B, Hasselgren K, Røsok B, Larsen PN, Urdzik J, Schultz NA, Carling U, Fallentin E, Gilg S, Sandström P, Lindell G, Sparrelid E. Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study. Int J Surg. 2020 Mar; 75:60-65.
    View in: PubMed
    Score: 0.097
  42. Sandström P, Larsson AL, Björnsson B, Røsok BI, Sparrelid E, Larsen PN, Schultz NA, Björnbeth BA, Lindell G, Isaksson B, Rizell M. Response to Comment on "When Innovation Is Not Enough". Ann Surg. 2019 08; 270(2):e36-e37.
    View in: PubMed
    Score: 0.093
  43. Sandström P, Røsok BI, Sparrelid E, Lindell G, Nørgaard Larsen P, Lindhoff Larsson A, Schultz NA, Bjørnbeth BA, Isaksson B, Rizell M, Björnsson B. Response to the Comment on "Should We Have a Little More Patience With the Conventional 2-Stage Hepatectomy?" Ann Surg. 2019 03; 269(3):e33-e34.
    View in: PubMed
    Score: 0.091
  44. Sandström P, Røsok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Rizell M, Björnsson B. Response to "ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases". Ann Surg. 2019 01; 269(1):e16-e17.
    View in: PubMed
    Score: 0.090
  45. Sandström P, Rösok BI, Sparrelid E, Lindell G, Larsen PN, Larsson AL, Schultz NA, Isaksson B, Rizell M, Björnsson B. Response: "Unresectable Colorectal Liver Metastases: When Definitions Matter to Appropriately Assess Extreme Liver Resection Techniques". Ann Surg. 2018 12; 268(6):e83-e85.
    View in: PubMed
    Score: 0.089
  46. Hasselgren K, Sandström P, Røsok BI, Sparrelid E, Lindell G, Larsen PN, Larsson AL, Schultz NA, Björnbeth BA, Isaksson B, Rizell M, Björnsson B. Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO. J Gastrointest Surg. 2019 03; 23(3):556-562.
    View in: PubMed
    Score: 0.089
  47. Sandström P, Røsok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Rizell M, Björnsson B. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). Ann Surg. 2018 05; 267(5):833-840.
    View in: PubMed
    Score: 0.086
  48. Sparrelid E. Reply to "Comment to Sparrelid, E. et al. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Journal of Gastrointestinal Surgery (2017)". J Gastrointest Surg. 2017 10; 21(10):1756.
    View in: PubMed
    Score: 0.081
  49. Olthof PB, Tomassini F, Huespe PE, Truant S, Pruvot FR, Troisi RI, Castro C, Schadde E, Axelsson R, Sparrelid E, Bennink RJ, Adam R, van Gulik TM, de Santibanes E. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function. Surgery. 2017 10; 162(4):775-783.
    View in: PubMed
    Score: 0.081
  50. Gilg S, Sparrelid E, Isaksson B, Lundell L, Nowak G, Strömberg C. Mortality-related risk factors and long-term survival after 4460 liver resections in Sweden-a population-based study. Langenbecks Arch Surg. 2017 Feb; 402(1):105-113.
    View in: PubMed
    Score: 0.077
  51. Sparrelid E, Del Chiaro M. Microvascular Invasion in Hepatitis B Virus-Related Hepatocellular Carcinoma: Another Step Toward Preoperative Evaluation? JAMA Surg. 2016 Apr; 151(4):364.
    View in: PubMed
    Score: 0.074
  52. Björnsson B, Sparrelid E, Hasselgren K, Gasslander T, Isaksson B, Sandström P. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases. Scand J Surg. 2016 Sep; 105(3):158-62.
    View in: PubMed
    Score: 0.074
  53. Björnsson B, Sparrelid E, Røsok B, Pomianowska E, Hasselgren K, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. Eur J Surg Oncol. 2016 Apr; 42(4):531-7.
    View in: PubMed
    Score: 0.073
  54. Røsok BI, Björnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
    View in: PubMed
    Score: 0.072
  55. Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015 Jun; 17(6):529-35.
    View in: PubMed
    Score: 0.069
  56. Ringdén O, Söderdahl G, Mattsson J, Uzunel M, Remberger M, Hentschke P, Hägglund H, Sparrelid E, Elmhorn-Rosenborg A, Duraj F, Zetterquist H, Ericzon BG. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer. Transplantation. 2000 May 27; 69(10):2043-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)